Patents by Inventor Jianqing Li

Jianqing Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Resetable over-current and/or over-temperature protection system
    Publication number: 20060109074
    Abstract: An electrical protection system, which can be connected between an electrical power supply and an electrical load, firstly includes a switch switchable between a normal state in which the switch is electrically connected in series between the power supply and the load such that an operating current passes through the switch and the load, and a fault sate in which the switch is disconnected with the load such that no current passes through the load. The switch switches to the fault state in an over-current or an over-temperature situation.
    Type: Application
    Filed: November 23, 2004
    Publication date: May 25, 2006
    Inventors: Yim-Shu Lee, Jianqing Li, Martin Chow, Kam-Wah Siu
  • Substituted cycloalkyl P1? hepatitis C virus inhibitors
    Patent number: 6878722
    Abstract: The present invention relates to tripeptide compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositions containing such analogs and methods for using these analogs in the treatment of HCV infection.
    Type: Grant
    Filed: May 20, 2003
    Date of Patent: April 12, 2005
    Assignee: Bristol-Myers Squibb Company
    Inventors: Jeffrey Allen Campbell, Stanley D'Andrea, Andrew Good, Jianqing Li, Fiona Mcphee, Amy Ripka, Paul Michael Scola, Yong Tu
  • S-6-hydroxy-buspirone
    Patent number: 6821976
    Abstract: The S-stereoisomer of 6-hydroxy-buspirone is an effective treatment for anxiety, depression, and other psychogenic disorders. The S-isomer may provide reduced potential for adverse effects and a longer duration of action compared to the racemic mixture and with buspirone.
    Type: Grant
    Filed: July 22, 2002
    Date of Patent: November 23, 2004
    Assignee: Bristol-Myers Squibb Company
    Inventors: Joseph P. Yevich, Robert F. Mayol, Jianqing Li, Frank Yocca
  • Substituted cycloalkyl P1' hepatitis C virus inhibitors
    Publication number: 20040077551
    Abstract: The present invention relates to tripeptide compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositions containing such analogs and methods for using these analogs in the treatment of HCV infection.
    Type: Application
    Filed: May 20, 2003
    Publication date: April 22, 2004
    Inventors: Jeffrey Allen Campbell, Stanley D'Andrea, Andrew Good, Jianqing Li, Fiona Mcphee, Amy Ripka, Paul Michael Scola, Yong Tu
  • R-6-hydroxy-buspirone
    Patent number: 6686361
    Abstract: The R-stereoisomer of 6-hydroxy-buspirone is an effective treatment for anxiety, depression, and other psychogenic disorders. The R-isomer exhibits greater receptor specificity than the S-isomer and should have reduced potential for the adverse effects associated with the racemic mixture and with buspirone.
    Type: Grant
    Filed: July 22, 2002
    Date of Patent: February 3, 2004
    Assignee: Bristol-Myers Squibb Company
    Inventors: Joseph P. Yevich, Robert F. Mayol, Jianqing Li, Frank Yocca
  • Antianxiety composition
    Publication number: 20030069251
    Abstract: An improved method of treating anxious patients involves direct administration of 6-hydroxy-8-[4-[4-(2-pyrimidinyl)-piperazinyl]-butyl]-8-azaspiro[4.5]-7,9-dione (BMY 28674) or a pharmaceutically acceptable salt or hydrate formulated in appropriate pharmaceutical compositions to patients in need of such treatment. Syntheses of BMY 28674 are also provided.
    Type: Application
    Filed: July 23, 2002
    Publication date: April 10, 2003
    Inventors: Joseph P. Yevich, Robert F. Mayol, Jianqing Li, Edward H. Ruediger
  • R-6-hydroxy-buspirone
    Publication number: 20030055063
    Abstract: The R-stereoisomer of 6-hydroxy-buspirone is an effective treatment for anxiety, depression, and other psychogenic disorders. The R-isomer exhibits greater receptor specificity than the S-isomer and should have reduced potential for the adverse effects associated with the racemic mixture and with buspirone.
    Type: Application
    Filed: July 22, 2002
    Publication date: March 20, 2003
    Inventors: Joseph P. Yevich, Robert F. Mayol, Jianqing Li, Frank Yocca
  • S-6-hydroxy-buspirone
    Publication number: 20030022899
    Abstract: The S-stereoisomer of 6-hydroxy-buspirone is an effective treatment for anxiety, depression, and other psychogenic disorders. The S-isomer may provide reduced potential for adverse effects and a longer duration of action compared to the racemic mixture and with buspirone.
    Type: Application
    Filed: July 22, 2002
    Publication date: January 30, 2003
    Inventors: Joseph P. Yevich, Robert F. Mayol, Jianqing Li, Frank Yocca